Hot Pursuit     20-Jun-14
Orchid Chemicals jumps on USFDA nod for a medicine
Orchid Chemicals & Pharmaceuticals surged 6.12% to Rs 76.25 at 9:17 IST on BSE after the company said it has received approval from USFDA for its abbreviated new drug application for Eszopiclone tablets, 1 mg, 2 mg, and 3 mg strengths.

The announcement was made after market hours on Thursday, 19 June 2014.

Meanwhile, the S&P BSE Sensex was up 26.65 points or 0.11% at 25,228.45.

On BSE, so far 1.47 lakh shares were traded in the counter as against average daily volume of 7.97 lakh shares in the past two weeks.

The stock hit a high of Rs 76.80 and a low of Rs 75.10 so far during the day.

Orchid Chemicals & Pharmaceuticals reported a net loss of Rs 80.79 crore in the quarter ended 31 March 2014, lower than net loss of Rs 132.27 crore in the quarter ended 31 March 2013. Net sales rose 67.2% to Rs 448.46 crore in the quarter ended 31 March 2014 over the quarter ended 31 March 2013.

Orchid Chemicals & Pharmaceuticals is involved in the development, manufacture and marketing of diverse bulk activities, formulations and nutraceuticals.

Previous News
  Orchid Pharma reports consolidated net loss of Rs 15.01 crore in the June 2022 quarter
 ( Results - Announcements 11-Aug-22   08:49 )
  Orchid Pharma to declare Quarterly Result
 ( Corporate News - 08-Aug-23   16:04 )
  Orchid Pharma to conduct AGM
 ( Corporate News - 24-Jul-21   15:09 )
  Orchid Pharma reports consolidated net loss of Rs 5.39 crore in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:28 )
  Orchid Pharma hits the roof on launching QIP issue
 ( Hot Pursuit - 23-Jun-23   11:26 )
  Broader mkt underperforms; metal stocks lose shine
 ( Market Commentary - Mid-Session 23-Jun-23   11:35 )
  Orchid Pharma to announce Quarterly Result
 ( Corporate News - 11-Nov-19   15:57 )
  Orchid Pharma reports standalone net loss of Rs 94.02 crore in the December 2015 quarter
 ( Results - Announcements 08-Mar-16   08:53 )
  Orchid Pharma to convene board meeting
 ( Corporate News - 07-Feb-22   10:23 )
  Orchid Pharma advances after USFDA nod for antipsychotic tablets
 ( Hot Pursuit - 13-Dec-17   15:05 )
  Orchid Pharma reports standalone net loss of Rs 166.28 crore in the June 2016 quarter
 ( Results - Announcements 13-Aug-16   17:40 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top